Symmetry Peak Management’s MacroGenics MGNX Stock Holding History

Symmetry Peak Management’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-5,000	Closed	-$90K	–	195
2019 Q1	$90K	Buy	+5,000	New	+$86.4K	0.02%	167

Other funds holding MGNX

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Symmetry Peak Management's MGNX Position: Q2 2019 in Review

Symmetry Peak Management sold out of MacroGenics (MGNX) in Q2 2019, closing a stake of 5,000 shares — an estimated $90K sold.

Symmetry Peak Management first reported a position in MGNX in Q1 2019 and held it in 1 quarter. The position peaked at $90K in Q1 2019. 130 funds tracked by Wall St. Rank hold MGNX as of Q2 2019.

Symmetry Peak Management reported no remaining MacroGenics position as of Q2 2019 after selling out during the quarter.
Symmetry Peak Management sold 5,000 MacroGenics shares in Q2 2019, an estimated $90K.
Symmetry Peak Management first reported a position in MacroGenics in Q1 2019 and held it in 1 quarter.
Symmetry Peak Management's MacroGenics position peaked at $90K in Q1 2019.
130 funds tracked by Wall St. Rank held MacroGenics as of Q2 2019.

Based on Symmetry Peak Management's 13F filing for Q2 2019, filed 14 Aug 2019.